Even though data are not always consistent, IGF2 has been shown to act in an autocrine or paracrine fashion to promote the growth of a variety of neoplasia, including brain tumors, mammary carcinoma, pancreatic carcinoma, and ovarian carcinoma37. Here, IGF2 is linked to brain neoplasm.